Study identifier:NIS-SA-CRE-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Centralized pan-Middle East Survey on the undertreatment of hypercholesterolemia
Hypercholesterolemia
-
No
-
All
4053
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
ClinArt Company & Signen Clinical Discoveries
No locations available
Arms | Assigned Interventions |
---|